对于T细胞协会和模型药物负载的Carboxy-Terminal Phenylalanine-Modified Dendrimers的结构优化
Hiroya Shiba1, Tomoka Hirose1, Akinobu Sakai1
1Department of Applied Chemistry, Graduate School of Engineering, Osaka Metropolitan University, 1-1 Gakuen-cho, Naka-ku, Sakai 599-8531, Osaka, Japan.
Pharmaceutics
|June 27, 2024
概括
用氨修改的聚胺胺 (PAMAM) 树突体显示出强烈的T细胞关联和药物负载. PAMAM-CHex-Phe是一种有前途的纳米载体,用于向免疫细胞的药物输送.
科学领域:
- 纳米技术纳米技术
- 药物运输 药物运输 药物运输
- 免疫学 免疫学 免疫学
背景情况:
- 丹德里默是精确可控的纳米载体,用于药物输送.
- 之前的研究表明,用1,2-环氨基酸 (CHex) 和氨酸 (Phe) 修改的聚胺胺 (PAMAM) 树突与T细胞结合.
研究的目的:
- 合成和评估卡基末端Phe-修饰的树枝状体,以检测T细胞协会.
- 调查有前途的树枝状分子候选者的药物负载和细胞毒性.
主要方法:
- 通过使用酸和线性二酸合成了各种碳氧终端Phe-修饰的树枝体.
- 评估了与Jurkat T细胞的树枝状细胞的关联.
- 装载模型药物 (原波林IX,帕克利塔塞尔) 在树枝状体上.
- 药物载荷树枝状体的评估细胞毒性.
主要成果:
- PAMAM-n-hexyl-Phe与Jurkat T细胞的相关性最高.
- 树突移植聚氨酸 (DGL) -CHex-Phe表现出较高的T细胞协会,但水溶性较差.
- PAMAM-CHex-Phe表现出优越的药物载荷能力.
- 带有PTX的PAMAM-CHex-Phe显示出与自由帕克利塔塞尔可比的细胞毒性.
结论:
- PAMAM-CHex-Phe是一种合适的纳米载体,具有高效的T细胞结合和药物加载能力.
- 这种树枝状分子显示出向向T细胞药物输送的潜力.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


